Research Methodology – Radioligand Therapy Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Radioligand Therapy Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Radioligand Therapy Market is developed by integrating key market indicators and macroeconomic variables. These include:
1 Factors considered while calculating market size and share:
- Current usage of Radioligand Therapy and its prevalence globally.
- Number of players providing Radioligand Therapy and their geographical reach.
- Key market segments in terms of therapy types, diseases treated, and geographical region.
- The number of existing and potential end users including hospitals, clinics, and other healthcare institutions.
- The volume of Radioligand Therapies sold annually.
- Market potential: Requirement or demand for Radioligand Therapy.
- Analysis of cost prices, overall production cost and the profitability in the Radioligand Therapy market.
2 Key market Indicators:
- The current market size and predicted market growth.
- Prevalence and incidence rates of diseases treatable with Radioligand Therapy.
- Global healthcare expenditure.
- Radioligand Therapy adoption rates among healthcare providers.
- The annual sales revenue of Radioligand Therapy.
- Technological advancements in Radioligand Therapy.
- Changes in regulations or policy related to Radioligand Therapy.
3 Growth Trends:
- Growth in demand due to increasing prevalence of cancer and other diseases that require Radioligand Therapy.
- New technological advancements improving the efficiency and efficacy of Radioligand Therapy.
- Growth in the adoption of Radioligand Therapy in emerging economies.
- Partnership and collaboration among key market players to expand Radioligand Therapy services.
- Increasing investment and funding in healthcare and research and development.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Radioligand Therapy Market. Key inputs include:
Company-Level Information
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
Industry and Government Sources
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Radioligand Therapy Market
Market Intelligence Sources
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
Macro & Consumer Insights
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
Expert Insights & KOL Engagements
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
Focused Discussions & Panels
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
Data Validation & Business POV
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
Forecasting is carried out using proprietary models that combine:
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights